glycomics
SUGAR-seq, a single-cell method developed by researchers in Australia, is a first step towards analyzing differences in glycosylation in various cell types.
InterVenn Biosciences Raises $34M in Series B Round to Commercialize Ovarian Cancer Test
The company also announced John Leite, the former leader of clinical business development activities at Illumina, had joined the firm as chief business officer.
Gastric Cancer Analysis in Young Populations Identifies Four Subtypes
The subtypes — which were distinguished from one another using proteomic data — were associated with proliferation, immune response, metabolism, and invasion.
InterVenn BioSciences Raises $9.4M in Funding
The company plans to use the funds to develop and commercialize its lead product, a mass spectrometry-based glycoproteomic blood test for ovarian cancer.
Waters, A*Star Extend Glycan Cancer Biomarkers Partnership
The mass spectrometry instrument maker will provide A*Star's Bioprocessing Technology Institute with expertise and access to a Synapt G2-S instrument.